Notícias Eulerpool Urogen Pharma

Urogen Pharma Notícias de ações

Urogen Pharma é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Urogen Pharma nós reunimos aqui.

• 5 de novembro ·

  Yahoo
  UroGen Pharma to Present at the Guggenheim Securities Healthcare Innovation Conference
• 30 de outubro ·

  Yahoo
  UroGen Pharma to Report Third Quarter Financial Results on Wednesday, November 6, 2024
• 28 de outubro ·

  Yahoo
  ENVISION Trial Results Published in the Journal of Urology Report 82.3% Duration of Response 12 Months after Achieving Complete Response for UGN-102, Potentially First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC
• 28 de outubro ·

  Thefly.com
  UroGen Pharma reports durability of response results from ENVISION study
• 19 de outubro ·

  Yahoo
  Investors in UroGen Pharma (NASDAQ:URGN) have unfortunately lost 42% over the last five years
• 16 de outubro ·

  Yahoo
  FDA accepts UroGen’s UGN-102 NDA for bladder cancer treatment
• 16 de outubro ·

  TipRanks
  Urogen Pharma (URGN) Receives a Buy from Oppenheimer
• 16 de outubro ·

  TipRanks
  TD Cowen Keeps Their Buy Rating on Urogen Pharma (URGN)
• 16 de outubro ·

  Thefly.com
  UroGen Pharma price target raised by $4 at H.C. Wainwright, here's why
• 15 de outubro ·

  Yahoo
  UroGen Announces FDA Acceptance of its New Drug Application for UGN-102